Ferozsons Laboratories Limited (PSX:FEROZ)
291.53
+3.27 (1.13%)
At close: May 13, 2025
Ferozsons Laboratories Revenue
Ferozsons Laboratories had revenue of 5.09B PKR in the quarter ending March 31, 2025, with 36.00% growth. This brings the company's revenue in the last twelve months to 18.16B, up 20.01% year-over-year. In the fiscal year ending June 30, 2024, Ferozsons Laboratories had annual revenue of 15.85B with 38.38% growth.
Revenue (ttm)
18.16B
Revenue Growth
+20.01%
P/S Ratio
0.70
Revenue / Employee
9.58M
Employees
1,896
Market Cap
12.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 15.85B | 4.40B | 38.38% |
Jun 30, 2023 | 11.46B | 2.13B | 22.80% |
Jun 30, 2022 | 9.33B | 450.80M | 5.08% |
Jun 30, 2021 | 8.88B | 2.67B | 42.93% |
Jun 30, 2020 | 6.21B | 409.49M | 7.06% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.15B |
Abbott Laboratories (Pakistan) | 69.49B |
AGP Limited | 26.27B |
Highnoon Laboratories | 25.51B |
The Searle Company | 28.80B |
Shifa International Hospitals | 26.63B |
Citi Pharma | 13.19B |
Otsuka Pakistan | 3.69B |